US04963C2098 - Common Stock
ATRICURE INC
NASDAQ:ATRC (4/23/2024, 7:00:00 PM)
After market: 23.17 0 (0%)23.17
+0.46 (+2.03%)
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 1,050 full-time employees. The company went IPO on 2005-08-05. The firm develops, manufactures and sells devices designed primarily for the surgical ablation of cardiac tissue, systems designed for the exclusion of the LAA and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers. Its ablation and left atrial appendage (LAA) management products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System.
ATRICURE INC
7555 Innovation Way
Mason OHIO 45040
P: 15137554100
CEO: Michael H. Carrel
Employees: 1050
Website: https://www.atricure.com
Here you can normally see the latest stock twits on ATRC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: